20-9565907-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1
The NM_177990.4(PAK5):c.1468C>T(p.Leu490=) variant causes a synonymous change. The variant allele was found at a frequency of 0.0559 in 1,612,356 control chromosomes in the GnomAD database, including 3,935 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.052 ( 372 hom., cov: 32)
Exomes 𝑓: 0.056 ( 3563 hom. )
Consequence
PAK5
NM_177990.4 synonymous
NM_177990.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 5.81
Genes affected
PAK5 (HGNC:15916): (p21 (RAC1) activated kinase 5) The protein encoded by this gene is a member of the PAK family of Ser/Thr protein kinases. PAK family members are known to be effectors of Rac/Cdc42 GTPases, which have been implicated in the regulation of cytoskeletal dynamics, proliferation, and cell survival signaling. This kinase contains a CDC42/Rac1 interactive binding (CRIB) motif, and has been shown to bind CDC42 in the presence of GTP. This kinase is predominantly expressed in brain. It is capable of promoting neurite outgrowth, and thus may play a role in neurite development. This kinase is associated with microtubule networks and induces microtubule stabilization. The subcellular localization of this kinase is tightly regulated during cell cycle progression. Alternatively spliced transcript variants encoding the same protein have been described. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -18 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.46).
BP6
Variant 20-9565907-G-A is Benign according to our data. Variant chr20-9565907-G-A is described in ClinVar as [Benign]. Clinvar id is 1676927.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.266 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PAK5 | NM_177990.4 | c.1468C>T | p.Leu490= | synonymous_variant | 5/10 | ENST00000353224.10 | |
LOC105372523 | XR_937250.3 | n.161+2806G>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PAK5 | ENST00000353224.10 | c.1468C>T | p.Leu490= | synonymous_variant | 5/10 | 1 | NM_177990.4 | P1 | |
PAK5 | ENST00000378423.5 | c.1468C>T | p.Leu490= | synonymous_variant | 6/11 | 1 | P1 | ||
PAK5 | ENST00000378429.3 | c.1468C>T | p.Leu490= | synonymous_variant | 6/11 | 1 | P1 | ||
ENST00000657954.1 | n.161+2806G>A | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.0523 AC: 7948AN: 151950Hom.: 369 Cov.: 32
GnomAD3 genomes
AF:
AC:
7948
AN:
151950
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0641 AC: 16052AN: 250370Hom.: 1081 AF XY: 0.0645 AC XY: 8729AN XY: 135274
GnomAD3 exomes
AF:
AC:
16052
AN:
250370
Hom.:
AF XY:
AC XY:
8729
AN XY:
135274
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0563 AC: 82253AN: 1460288Hom.: 3563 Cov.: 32 AF XY: 0.0562 AC XY: 40852AN XY: 726448
GnomAD4 exome
AF:
AC:
82253
AN:
1460288
Hom.:
Cov.:
32
AF XY:
AC XY:
40852
AN XY:
726448
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0523 AC: 7947AN: 152068Hom.: 372 Cov.: 32 AF XY: 0.0540 AC XY: 4016AN XY: 74352
GnomAD4 genome
AF:
AC:
7947
AN:
152068
Hom.:
Cov.:
32
AF XY:
AC XY:
4016
AN XY:
74352
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
514
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 12, 2022 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at